Researchers observed significant fibrosis in more than one-third of patients with hepatitis B and HIV coinfection undergoing long-term combination antiretroviral therapy with viral suppression, according to a study published in American Journal of Gastroenterology.
“HIV treatment guidelines recommend that all HIV-infected persons with active HBV infection … undergo treatment of both infections with [combination ART] including tenofovir,” Richard K. Sterling, MD, MSc, FACG, from Virginia Commonwealth University, and colleagues wrote. “Our data provides novel and clinically

Source link